Fulgent Genetics, Inc. Common Stock (FLGT) is a publicly traded Healthcare sector company. As of July 30, 2026, FLGT trades at $16.64 with a market cap of $557.79M and a P/E ratio of 0.00. FLGT moved +2.80% today. Year to date, FLGT is -21.02%; over the trailing twelve months it is +15.55%. Its 52-week range spans $13.46 to $31.04. Analyst consensus is neutral with an average price target of $15.00. Rallies surfaces FLGT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for FLGT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $16.64 |
| Market Cap | $557.79M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.04 |
| 52-Week Low | $13.46 |
| Volume | 215.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $320.35M |
| Net Income | $-75.01M |
| Gross Margin | 38.71% |
1 analysts cover FLGT: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $15.00.